Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Charles J. Ryan
Based on 106 articles published since 2007
||||
Expertise Level
The expertise of Charles J. Ryan ranks in the
  • Top 0.017%
  • ... of 132,893 published authors worldwide on Prostatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 106 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Ryan, C J   ·   Ryan, Charles J   ·   Ryan, Charles
Work Locations
Details
Most likely:    University of California San Francisco   Contact    
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • Division of Genitourinary Medical Oncology, University of California, San Francisco, CA. Electronic address: · Knight Cancer Institute, Oregon Health and Science University, Portland, OR. · Department of Medicine, University of California, San Francisco, CA. · Division of Genitourinary Medical Oncology, University of California, San Francisco, CA. · Biostatistics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. · Department of Urology, University of California, San Francisco, CA. · Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA. · Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH. · Epic Biosciences, La Jolla, CA. · Division of Genitourinary Medical Oncology, University of California, San Francisco, CA; Department of Urology, University of California, San Francisco, CA. · Pubmed 28655452
  • Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York. · Massachusetts General Hospital and Harvard Medical School, Boston. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Cancer Centers of North Carolina, Raleigh. · Carolina Urologic Research Center, Myrtle Beach. · University of Wisconsin Carbone Cancer Center, Madison. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle. · Knight Cancer Institute, Oregon Health & Science University, Portland. · Nebraska Cancer Specialists, Omaha. · Chesapeake Urologic Research Associates, Baltimore. · University of Alabama Comprehensive Cancer Center, Birmingham. · Aragon Pharmaceuticals, San Diego. · Janssen Research & Development, Spring House. · Janssen Research & Development, Los Angeles. · Janssen Biologics, B. V., Leiden, the Netherlands. · Janssen Research & Development, San Diego. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, USA. · Pubmed 28633425
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, California, USA · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, California, USA. · Pubmed 28314838
  • Sidney Kimmel Center for Prostate and Urologic Cancers, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Chesapeake Urologic Research Associates, Baltimore, Maryland. · Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · University of Alabama Comprehensive Cancer Center, Birmingham, Alabama. · Nebraska Cancer Specialists, Omaha, Nebraska. · Janssen Research & Development, Philadelphia, Pennsylvania. · Aragon Pharmaceuticals, San Diego, California. · Janssen Biologics, B.V., Leiden, the Netherlands. · Janssen Research & Development, Los Angeles, California. · Sidney Kimmel Center for Prostate and Urologic Cancers, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Pubmed 28213364
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Mayo Scottsdale Cancer Center, Scottsdale, AZ. · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. · Department of Medicine, Vanderbilt University, Nashville, TN. · Pubmed 28161323
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Sage Bionetworks, Seattle, WA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Mathematics and Statistics, University of Turku, Turku, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Information Technology, University of Turku, Turku, Finland. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; Department of Pathology (HUSLAB), Helsinki University Hospital, Helsinki, Finland. · Sanofi, Bridgewater, NJ, USA. · AstraZeneca, Gaithersburg, MD, USA. · IBM T J Watson Research Center, IBM, Yorktown Heights, NY, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Genitourinary Medical Oncology Program, Division of Hematology and Oncology, University of California, San Francisco, CA, USA. · Genitourinary Oncology Services, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; The Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA; University of Colorado Comprehensive Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Electronic address: · Pubmed 27864015
  • Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · University of Montréal, Montréal, QC, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Pubmed 27324190
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California. · Department of Pathology, Duke University, Durham, North Carolina. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California. · Pubmed 28592703
  • Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California · Department of Radiology, San Francisco VA Medical Center, San Francisco, California. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California. · Department of Urology, University of California San Francisco, San Francisco, California; and. · Department of Radiation Oncology, University of California San Francisco, San Francisco, California. · Pubmed 28522741
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Epidemiology and Biostatistics, UCSF, San Francisco, California. · Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Radiation Oncology, UCSF, San Francisco, California. · Division of Hematology and Oncology, UCSF, San Francisco, California. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Department of Pathology, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan. · Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Medicine, UCSF, San Francisco, California. · Pubmed 28450426
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California · Department of Radiology, San Francisco VA Medical Center, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California. · Department of Radiology, Mayo Clinic, Rochester, Minnesota. · Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany. · Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California; and. · Department of Urology, University of California, San Francisco, San Francisco, California. · Pubmed 27660139
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
2016
  • Genitourinary Medical Oncology Program, Division of Hematology & Oncology, University of California, San Francisco, CA 94143, USA. · Pubmed 26690748
  • Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. · Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Pubmed 27450893
  • Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. · Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA · Pubmed 27317574
  • Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA. · Servicio de Oncologia Medica, Hospital Universitario La Paz, Madrid, Spain. · Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA. Electronic address: · Pubmed 26944450
  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. Electronic address: · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Cancer Centers of North Carolina, Raleigh, NC, USA. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · University of Wisconsin Carbone Cancer Center, Madison, WI, USA. · Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Aragon Pharmaceuticals, San Diego, CA, USA. · Janssen Research & Development, Spring House, PA, USA. · Janssen Biologics, B.V., Leiden, The Netherlands. · Janssen Research & Development, Los Angeles, CA, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Pubmed 27160947
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France · University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, USA. · Saarland University, Homburg/Saar, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, San Diego. · Janssen Research & Development, Raritan. · Janssen Global Services, Raritan. · Janssen Research & Development, Los Angeles. · Janssen Research & Development, Menlo Park, USA. · Pubmed 26609008
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Urology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Hematology and Medical Oncology Cleveland, Clinic Taussig Cancer Institute, Cleveland, Ohio. · Department of Urology, University of California, San Diego, La Jolla, California. · Department of Anatomic Pathology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 27688020
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • Genitourinary Medical Oncology Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. Electronic address: · Pubmed 27267736
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Pubmed 27209539
2015
  • University of California, San Francisco, San Francisco, CA. · University of California, San Francisco, San Francisco, CA · Pubmed 25547509
  • Department of Genitourinary Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Electronic address: · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Urology, University Hospitals of KU Leuven, Leuven, Belgium. · Department of Biostatistics Oncology, Janssen Research & Development, Raritan, New Jersey. · Department of Biostatistics and Programming, Janssen Research & Development, San Diego, California. · Department of WC Clinical Oncology, Janssen Research & Development, Los Angeles, California. · Department of Oncology, Janssen Research & Development, Los Angeles, California. · Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California. · Pubmed 26151676
  • Division of Hematology/Oncology, University of California, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco, California. UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco, California. UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Pubmed 25968455
  • Janssen Research & Development, Raritan, New Jersey. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Janssen Research & Development, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · University of Montreal, Montreal, Quebec, Canada. · Janssen Research & Development, Los Angeles, California. · Janssen Research & Development, Raritan, New Jersey. · Pubmed 25829400
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Department of Medicine, University of California San Francisco, San Francisco, CA. Electronic address: · Department of Medicine, Oregon Health Sciences University, Knight Cancer Institute, Portland, OR. · Department of Medicine, University of California San Francisco, San Francisco, CA. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA. · Urology Cancer Center and GU Research Network, Omaha, NE. · Pubmed 25557266
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: · Janssen Research and Development, Los Angeles, CA, USA. · Janssen Research and Development, Menlo Park, CA, USA. · Janssen Research and Development, Raritan, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, Villejuif, France. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, UK. · Pubmed 25018037
2014
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Department of Medicine, PK/PD Core Resource, Roswell Park Cancer Institute, Buffalo, New York. · Department of Urology, Roswell Park Cancer Institute, Buffalo, New York. · Section of Hematology and Oncology, University of Chicago, Chicago, Illinois. · Janssen Research and Development, Menlo Park, California. · Pubmed 25336698
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; · MD Anderson Cancer Center, Houston, Texas; · Massachusetts General Hospital Cancer Center, Boston; · Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; · Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon; · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; · University of Wisconsin Carbone Cancer Center, Madison, Wisconsin; and. · Takeda Pharmaceuticals International Co.; · Millennium: The Takeda Oncology Company, Cambridge, Massachusetts; · Duke University Medical Center, Durham, North Carolina. · Pubmed 24965748
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, Los Angeles, CA. · Pubmed 24787968
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Endocrine Sciences, LabCorp, Calabasas, CA, USA. · Memorial Sloan Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 24637537
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Department of Molecular Pharmacology, City of Hope, Duarte, CA, USA. · Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. · Atara Biotherapeutics, Westlake Village, CA, USA. · Janssen Research and Development, Los Angeles, CA, USA. · Pubmed 25047002
2013
  • Genitourinary Medical Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA. · Pubmed 23199349
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 23816964
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 23136195
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA. · Pubmed 24200767
  • Genitourinary Medical Oncology Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA. · Pubmed 23228172
2012
  • UCSF Helen Diller Family Comprehensive Cancer, San Francisco, California, USA. · Pubmed 22402426
2011
  • UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, San Francisco, CA 94115, USA. · Pubmed 21859989
  • Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94115, USA. · Pubmed 21632851
2010
  • Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 21326154
  • Urologic Oncology Program, University of California, San Francisco, San Francisco, CA 94115, USA. · Pubmed 20159824
2008
  • Department of Medicine, University of California, San Francisco, California 94143, USA. · Pubmed 18491370
  • Department of Medicine and the [corrected] UCSF Comprehensive Cancer Center, University of California San Francisco, CA 94143, USA. · Pubmed 18234062
2007
  • Department of Medicine and University of California-San Francisco Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94143, USA. · Pubmed 17644122
  • Urologic Oncology Program, University of California-San Francisco Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94115, USA. · Pubmed 17936834
  • Urologic Oncology Program, UCSF Comprehensive Cancer Center, 1600 Divisadero-3rd Floor, San Francisco, CA, USA. · Pubmed 17458505
  • Urologic Oncology Program, University of California,/San Francisco, California 94143, USA. · Pubmed 17404083
  • Department of Medicine, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA. · Pubmed 17516446
  • Department of Medicine, UCSF Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA. <> · Pubmed 17349528
2017
  • aDivision of Hematology/Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California bDepartment of Radiation Oncology, Weill Cornell Medicine, New York, New York, USA. · Pubmed 28786849
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
2015
  • Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL. · Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL. · Pubmed 25605863
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California. · Pubmed 25236176
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • From the *Department of Radiology and Biomedical Imaging, †Division of Hematology/Oncology, Department of Medicine, Departments of ‡Pathology, §Urology, and ∥Radiation Oncology, University of California San Francisco, San Francisco, CA. · Pubmed 25783510
2014
  • Matthew R. Smith and Philip Saylor, Massachusetts General Hospital Cancer Center, Boston, MA; Susan Halabi and Ben Sanford, Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC; Charles J. Ryan and Eric J. Small, University of California at San Francisco, San Francisco, CA; Walter Stadler, University of Chicago; Nirmala Bhoopalam, Loyola University of Chicago, Chicago, IL; Arif Hussain, University of Maryland, Baltimore, MD; Nicholas Vogelzang, Nevada Cancer Research Foundation CCOP, Las Vegas, NV; Ralph J. Hauke, University of Nebraska, Omaha, NE; J. Paul Monk, Ohio State University, Columbus, OH; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Michael Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 24590644
  • Division of Genitourinary Medical Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. · Pubmed 24166007
2013
  • Division of Hematology/Oncology, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA. · Pubmed 21658978
2012
  • Division of Genitourinary Medical Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA. · Pubmed 23084523
  • Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA. · Pubmed 22539224
  • Genitourinary Medical Oncology Program, Biostatistics and Computational Biology Core, Helen Diller Family Comprehensive Cancer Center, Department of Bioengineering and Therapeutic Sciences, Box 1711, 1600 Divisadaro Street, University of California, San Francisco, San Francisco, CA 94115-1711, USA. · Pubmed 21971890
  • Urologic Oncology Program, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94143, USA. · Pubmed 20884247
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, USA. · Pubmed 22373240
  • Division on Genitourinary Medical Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA. · Pubmed 22158653
2011
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Pubmed 24048789
  • Department of Medicine, University of California, San Francisco, CA 94143-1270, USA. · Pubmed 21339259
2010
  • UCSF, Division of Hematology and Oncology, Department of Medicine, 1600 Divisadero St, Box 1711, San Francisco, CA 94115, USA. · Pubmed 20225998
2009
  • Urologic Oncology Program, UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA. · Pubmed 19342958
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, 1600 Divisadero Street, San Francisco, CA 94115, USA. · Pubmed 19336015
  • Urologic Oncology Program, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94115, USA. · Pubmed 19815485
  • Division of Hematology/Oncology, University of California, San Francisco, San Francisco, California 94143, USA. · Pubmed 19147575
  • Department of Medicine, University of California San Franscisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, Box 1711, San Francisco, CA 94115, USA. · Pubmed 19349545
2008
  • The Urologic Oncology Program, UCSF Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94143, USA. · Pubmed 18303477
  • Department of Medicine, University of California, San Francisco, 1600 Divisadero Street, Box 1711, San Francisco, CA 94115, USA. · Pubmed 18279066
  • University of California, Department of Medicine, Box 1711, San Francisco,1600 Divisadero Street, San Francisco, CA 94115, USA. · Pubmed 18095915
2007
  • Department of Medicine, and UCSF Comprehensive Cancer Center, University of California-San Francisco, 94143, USA. · Pubmed 17913662
  • UCSF Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA. · Pubmed 17645829
Probable:    Harvard University   Contact    
2014
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
2015
  • Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL. · Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL. · Pubmed 25605863
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2014
  • Matthew R. Smith and Philip Saylor, Massachusetts General Hospital Cancer Center, Boston, MA; Susan Halabi and Ben Sanford, Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC; Charles J. Ryan and Eric J. Small, University of California at San Francisco, San Francisco, CA; Walter Stadler, University of Chicago; Nirmala Bhoopalam, Loyola University of Chicago, Chicago, IL; Arif Hussain, University of Maryland, Baltimore, MD; Nicholas Vogelzang, Nevada Cancer Research Foundation CCOP, Las Vegas, NV; Ralph J. Hauke, University of Nebraska, Omaha, NE; J. Paul Monk, Ohio State University, Columbus, OH; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Michael Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 24590644
2009
  • Department of Medicine, University of California San Franscisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, Box 1711, San Francisco, CA 94115, USA. · Pubmed 19349545
Probable:    Tulane University   Contact    
2014
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 106 total) written by Charles J. Ryan about Prostatic Neoplasms:

  • Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer. 2017
  • Treatment strategies in low-volume metastatic castration-resistant prostate cancer. 2017
  • High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer. 2017
  • Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide. 2017
  • A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer. 2017
  • Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone. 2017
  • A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study. 2017
  • Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone. 2017
  • Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. 2017
  • Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer. 2017
Show List of Full Article Records
Google Searches

Learn more about Charles J. Ryan using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of California San Francisco
Harvard University
Tulane University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of California San Francisco
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • Division of Genitourinary Medical Oncology, University of California, San Francisco, CA. Electronic address: · Knight Cancer Institute, Oregon Health and Science University, Portland, OR. · Department of Medicine, University of California, San Francisco, CA. · Division of Genitourinary Medical Oncology, University of California, San Francisco, CA. · Biostatistics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. · Department of Urology, University of California, San Francisco, CA. · Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA. · Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH. · Epic Biosciences, La Jolla, CA. · Division of Genitourinary Medical Oncology, University of California, San Francisco, CA; Department of Urology, University of California, San Francisco, CA. · Pubmed 28655452
  • Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York. · Massachusetts General Hospital and Harvard Medical School, Boston. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Cancer Centers of North Carolina, Raleigh. · Carolina Urologic Research Center, Myrtle Beach. · University of Wisconsin Carbone Cancer Center, Madison. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle. · Knight Cancer Institute, Oregon Health & Science University, Portland. · Nebraska Cancer Specialists, Omaha. · Chesapeake Urologic Research Associates, Baltimore. · University of Alabama Comprehensive Cancer Center, Birmingham. · Aragon Pharmaceuticals, San Diego. · Janssen Research & Development, Spring House. · Janssen Research & Development, Los Angeles. · Janssen Biologics, B. V., Leiden, the Netherlands. · Janssen Research & Development, San Diego. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, USA. · Pubmed 28633425
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, California, USA · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, California, USA. · Pubmed 28314838
  • Sidney Kimmel Center for Prostate and Urologic Cancers, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Chesapeake Urologic Research Associates, Baltimore, Maryland. · Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · University of Alabama Comprehensive Cancer Center, Birmingham, Alabama. · Nebraska Cancer Specialists, Omaha, Nebraska. · Janssen Research & Development, Philadelphia, Pennsylvania. · Aragon Pharmaceuticals, San Diego, California. · Janssen Biologics, B.V., Leiden, the Netherlands. · Janssen Research & Development, Los Angeles, California. · Sidney Kimmel Center for Prostate and Urologic Cancers, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Pubmed 28213364
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Mayo Scottsdale Cancer Center, Scottsdale, AZ. · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. · Department of Medicine, Vanderbilt University, Nashville, TN. · Pubmed 28161323
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Sage Bionetworks, Seattle, WA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Mathematics and Statistics, University of Turku, Turku, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Information Technology, University of Turku, Turku, Finland. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; Department of Pathology (HUSLAB), Helsinki University Hospital, Helsinki, Finland. · Sanofi, Bridgewater, NJ, USA. · AstraZeneca, Gaithersburg, MD, USA. · IBM T J Watson Research Center, IBM, Yorktown Heights, NY, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Genitourinary Medical Oncology Program, Division of Hematology and Oncology, University of California, San Francisco, CA, USA. · Genitourinary Oncology Services, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; The Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA; University of Colorado Comprehensive Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Electronic address: · Pubmed 27864015
  • Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · University of Montréal, Montréal, QC, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, 920 Route 202, Raritan, NJ, 08869, USA. · Pubmed 27324190
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California. · Department of Pathology, Duke University, Durham, North Carolina. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California. · Pubmed 28592703
  • Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California · Department of Radiology, San Francisco VA Medical Center, San Francisco, California. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California. · Department of Urology, University of California San Francisco, San Francisco, California; and. · Department of Radiation Oncology, University of California San Francisco, San Francisco, California. · Pubmed 28522741
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Epidemiology and Biostatistics, UCSF, San Francisco, California. · Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Radiation Oncology, UCSF, San Francisco, California. · Division of Hematology and Oncology, UCSF, San Francisco, California. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Department of Pathology, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan. · Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Medicine, UCSF, San Francisco, California. · Pubmed 28450426
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California · Department of Radiology, San Francisco VA Medical Center, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California. · Department of Radiology, Mayo Clinic, Rochester, Minnesota. · Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany. · Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California; and. · Department of Urology, University of California, San Francisco, San Francisco, California. · Pubmed 27660139
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
2016
  • Genitourinary Medical Oncology Program, Division of Hematology & Oncology, University of California, San Francisco, CA 94143, USA. · Pubmed 26690748
  • Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. · Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address: · Pubmed 27450893
  • Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA. · Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA · Pubmed 27317574
  • Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA. · Servicio de Oncologia Medica, Hospital Universitario La Paz, Madrid, Spain. · Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA. Electronic address: · Pubmed 26944450
  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. Electronic address: · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Cancer Centers of North Carolina, Raleigh, NC, USA. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · University of Wisconsin Carbone Cancer Center, Madison, WI, USA. · Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Aragon Pharmaceuticals, San Diego, CA, USA. · Janssen Research & Development, Spring House, PA, USA. · Janssen Biologics, B.V., Leiden, The Netherlands. · Janssen Research & Development, Los Angeles, CA, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Pubmed 27160947
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France · University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, USA. · Saarland University, Homburg/Saar, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, San Diego. · Janssen Research & Development, Raritan. · Janssen Global Services, Raritan. · Janssen Research & Development, Los Angeles. · Janssen Research & Development, Menlo Park, USA. · Pubmed 26609008
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Urology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Hematology and Medical Oncology Cleveland, Clinic Taussig Cancer Institute, Cleveland, Ohio. · Department of Urology, University of California, San Diego, La Jolla, California. · Department of Anatomic Pathology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Pubmed 27688020
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • Genitourinary Medical Oncology Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. Electronic address: · Pubmed 27267736
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Pubmed 27209539
2015
  • University of California, San Francisco, San Francisco, CA. · University of California, San Francisco, San Francisco, CA · Pubmed 25547509
  • Department of Genitourinary Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Electronic address: · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Urology, University Hospitals of KU Leuven, Leuven, Belgium. · Department of Biostatistics Oncology, Janssen Research & Development, Raritan, New Jersey. · Department of Biostatistics and Programming, Janssen Research & Development, San Diego, California. · Department of WC Clinical Oncology, Janssen Research & Development, Los Angeles, California. · Department of Oncology, Janssen Research & Development, Los Angeles, California. · Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California. · Pubmed 26151676
  • Division of Hematology/Oncology, University of California, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco, California. UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Division of Hematology/Oncology, University of California, San Francisco, California. UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Pubmed 25968455
  • Janssen Research & Development, Raritan, New Jersey. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Janssen Research & Development, Beerse, Belgium. · Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · University of Montreal, Montreal, Quebec, Canada. · Janssen Research & Development, Los Angeles, California. · Janssen Research & Development, Raritan, New Jersey. · Pubmed 25829400
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Department of Medicine, University of California San Francisco, San Francisco, CA. Electronic address: · Department of Medicine, Oregon Health Sciences University, Knight Cancer Institute, Portland, OR. · Department of Medicine, University of California San Francisco, San Francisco, CA. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA. · Urology Cancer Center and GU Research Network, Omaha, NE. · Pubmed 25557266
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: · Janssen Research and Development, Los Angeles, CA, USA. · Janssen Research and Development, Menlo Park, CA, USA. · Janssen Research and Development, Raritan, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, Villejuif, France. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, UK. · Pubmed 25018037
2014
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. · Department of Medicine, PK/PD Core Resource, Roswell Park Cancer Institute, Buffalo, New York. · Department of Urology, Roswell Park Cancer Institute, Buffalo, New York. · Section of Hematology and Oncology, University of Chicago, Chicago, Illinois. · Janssen Research and Development, Menlo Park, California. · Pubmed 25336698
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; · MD Anderson Cancer Center, Houston, Texas; · Massachusetts General Hospital Cancer Center, Boston; · Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; · Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon; · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; · University of Wisconsin Carbone Cancer Center, Madison, Wisconsin; and. · Takeda Pharmaceuticals International Co.; · Millennium: The Takeda Oncology Company, Cambridge, Massachusetts; · Duke University Medical Center, Durham, North Carolina. · Pubmed 24965748
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, Los Angeles, CA. · Pubmed 24787968
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Endocrine Sciences, LabCorp, Calabasas, CA, USA. · Memorial Sloan Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 24637537
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Department of Molecular Pharmacology, City of Hope, Duarte, CA, USA. · Department of Neurology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. · Atara Biotherapeutics, Westlake Village, CA, USA. · Janssen Research and Development, Los Angeles, CA, USA. · Pubmed 25047002
2013
  • Genitourinary Medical Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA. · Pubmed 23199349
  • University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 23816964
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA. · Pubmed 23136195
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA. · Pubmed 24200767
  • Genitourinary Medical Oncology Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA. · Pubmed 23228172
2012
  • UCSF Helen Diller Family Comprehensive Cancer, San Francisco, California, USA. · Pubmed 22402426
2011
  • UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, San Francisco, CA 94115, USA. · Pubmed 21859989
  • Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94115, USA. · Pubmed 21632851
2010
  • Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Pubmed 21326154
  • Urologic Oncology Program, University of California, San Francisco, San Francisco, CA 94115, USA. · Pubmed 20159824
2008
  • Department of Medicine, University of California, San Francisco, California 94143, USA. · Pubmed 18491370
  • Department of Medicine and the [corrected] UCSF Comprehensive Cancer Center, University of California San Francisco, CA 94143, USA. · Pubmed 18234062
2007
  • Department of Medicine and University of California-San Francisco Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94143, USA. · Pubmed 17644122
  • Urologic Oncology Program, University of California-San Francisco Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94115, USA. · Pubmed 17936834
  • Urologic Oncology Program, UCSF Comprehensive Cancer Center, 1600 Divisadero-3rd Floor, San Francisco, CA, USA. · Pubmed 17458505
  • Urologic Oncology Program, University of California,/San Francisco, California 94143, USA. · Pubmed 17404083
  • Department of Medicine, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA. · Pubmed 17516446
  • Department of Medicine, UCSF Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA. <> · Pubmed 17349528
2017
  • aDivision of Hematology/Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California bDepartment of Radiation Oncology, Weill Cornell Medicine, New York, New York, USA. · Pubmed 28786849
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
2015
  • Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL. · Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL. · Pubmed 25605863
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California. · Pubmed 25236176
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • From the *Department of Radiology and Biomedical Imaging, †Division of Hematology/Oncology, Department of Medicine, Departments of ‡Pathology, §Urology, and ∥Radiation Oncology, University of California San Francisco, San Francisco, CA. · Pubmed 25783510
2014
  • Matthew R. Smith and Philip Saylor, Massachusetts General Hospital Cancer Center, Boston, MA; Susan Halabi and Ben Sanford, Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC; Charles J. Ryan and Eric J. Small, University of California at San Francisco, San Francisco, CA; Walter Stadler, University of Chicago; Nirmala Bhoopalam, Loyola University of Chicago, Chicago, IL; Arif Hussain, University of Maryland, Baltimore, MD; Nicholas Vogelzang, Nevada Cancer Research Foundation CCOP, Las Vegas, NV; Ralph J. Hauke, University of Nebraska, Omaha, NE; J. Paul Monk, Ohio State University, Columbus, OH; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Michael Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 24590644
  • Division of Genitourinary Medical Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. · Pubmed 24166007
2013
  • Division of Hematology/Oncology, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA. · Pubmed 21658978
2012
  • Division of Genitourinary Medical Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA. · Pubmed 23084523
  • Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA. · Pubmed 22539224
  • Genitourinary Medical Oncology Program, Biostatistics and Computational Biology Core, Helen Diller Family Comprehensive Cancer Center, Department of Bioengineering and Therapeutic Sciences, Box 1711, 1600 Divisadaro Street, University of California, San Francisco, San Francisco, CA 94115-1711, USA. · Pubmed 21971890
  • Urologic Oncology Program, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94143, USA. · Pubmed 20884247
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, USA. · Pubmed 22373240
  • Division on Genitourinary Medical Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA. · Pubmed 22158653
2011
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Pubmed 24048789
  • Department of Medicine, University of California, San Francisco, CA 94143-1270, USA. · Pubmed 21339259
2010
  • UCSF, Division of Hematology and Oncology, Department of Medicine, 1600 Divisadero St, Box 1711, San Francisco, CA 94115, USA. · Pubmed 20225998
2009
  • Urologic Oncology Program, UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA. · Pubmed 19342958
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, 1600 Divisadero Street, San Francisco, CA 94115, USA. · Pubmed 19336015
  • Urologic Oncology Program, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94115, USA. · Pubmed 19815485
  • Division of Hematology/Oncology, University of California, San Francisco, San Francisco, California 94143, USA. · Pubmed 19147575
  • Department of Medicine, University of California San Franscisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, Box 1711, San Francisco, CA 94115, USA. · Pubmed 19349545
2008
  • The Urologic Oncology Program, UCSF Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94143, USA. · Pubmed 18303477
  • Department of Medicine, University of California, San Francisco, 1600 Divisadero Street, Box 1711, San Francisco, CA 94115, USA. · Pubmed 18279066
  • University of California, Department of Medicine, Box 1711, San Francisco,1600 Divisadero Street, San Francisco, CA 94115, USA. · Pubmed 18095915
2007
  • Department of Medicine, and UCSF Comprehensive Cancer Center, University of California-San Francisco, 94143, USA. · Pubmed 17913662
  • UCSF Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA. · Pubmed 17645829
Harvard University
2014
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
2015
  • Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL. · Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL. · Pubmed 25605863
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2014
  • Matthew R. Smith and Philip Saylor, Massachusetts General Hospital Cancer Center, Boston, MA; Susan Halabi and Ben Sanford, Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC; Charles J. Ryan and Eric J. Small, University of California at San Francisco, San Francisco, CA; Walter Stadler, University of Chicago; Nirmala Bhoopalam, Loyola University of Chicago, Chicago, IL; Arif Hussain, University of Maryland, Baltimore, MD; Nicholas Vogelzang, Nevada Cancer Research Foundation CCOP, Las Vegas, NV; Ralph J. Hauke, University of Nebraska, Omaha, NE; J. Paul Monk, Ohio State University, Columbus, OH; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Michael Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · Pubmed 24590644
2009
  • Department of Medicine, University of California San Franscisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, Box 1711, San Francisco, CA 94115, USA. · Pubmed 19349545
Tulane University
2014
  • Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA · Department of Medicine, Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA; Educational Concepts Group, LLC, Atlanta, Georgia, USA; Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana, USA. · Pubmed 25232039
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
45 Other Locations Show
Yearly article counts 016131311108668510
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.